Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson’s disease
Open Access
- 30 April 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1375265
Abstract
Parkinson’s disease (PD) is characterized by three main motor symptoms: bradykinesia, rigidity and tremor. PD is also associated with diverse non-motor symptoms that may develop in parallel or precede motor dysfunctions, ranging from autonomic system dysfunctions and impaired sensory perception to cognitive deficits and depression. Here, we examine the role of the progressive loss of dopaminergic transmission in behaviors related to the non-motor symptoms of PD in a mouse model of the disease (the TIF-IADATCreERT2 strain). We found that in the period from 5 to 12 weeks after the induction of a gradual loss of dopaminergic neurons, mild motor symptoms became detectable, including changes in the distance between paws while standing as well as the swing speed and step sequence. Male mutant mice showed no apparent changes in olfactory acuity, no anhedonia-like behaviors, and normal learning in an instrumental task; however, a pronounced increase in the number of operant responses performed was noted. Similarly, female mice with progressive dopaminergic neuron degeneration showed normal learning in the probabilistic reversal learning task and no loss of sweet-taste preference, but again, a robustly higher number of choices were performed in the task. In both males and females, the higher number of instrumental responses did not affect the accuracy or the fraction of rewarded responses. Taken together, these data reveal discrete, dopamine-dependent non-motor symptoms that emerge in the early stages of dopaminergic neuron degeneration.Keywords
This publication has 112 references indexed in Scilit:
- Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal modelsBrain and Behavior, 2017
- Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson diseaseAnnals of Clinical and Translational Neurology, 2015
- Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptomsEuropean journal of pain, 2015
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of conceptsMovement Disorders, 2011
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Simple Behavioral Assessment of Mouse OlfactionCurrent Protocols in Neuroscience, 2009
- Levodopa unresponsive symptoms in Parkinson diseaseMovement Disorders, 2008
- Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsideredMovement Disorders, 2006
- A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's diseaseMovement Disorders, 2004
- Immunocytochemical localization of the dopamine transporter in human brainJournal of Comparative Neurology, 1999